PDS Biotech Logo.png
PDS Biotechnology to Present Recent Phase 2 Human Clinical Data and On-Going Oncology Programs at Investor Conferences
July 28, 2021 08:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., July 28, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
PDS Biotech Logo.png
PDS Biotechnology Announces Conference Call and Webcast to Present Second Quarter 2021 Financial Results
July 26, 2021 08:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., July 26, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
Immunicum Announces Positive Review by Data Safety Monitoring Board for Phase Ib Part of ILIAD Study
July 26, 2021 02:00 ET | Immunicum AB
Press Release 26 July 2021 Immunicum Announces Positive Review by Data Safety Monitoring Board for Phase Ib Part of ILIAD Study  -- Independent Data Safety and Monitoring Board (DSMB) issues...
Immunicum tillkännager positiv granskning från Data Safety Monitoring Board av fas Ib IILIAD-studien
July 26, 2021 02:00 ET | Immunicum AB
Press Release 26 July 2021  Immunicum tillkännager positiv granskning från Data Safety Monitoring Board av fas Ib IILIAD-studien -- Independent Data Safety and Monitoring Board (DSMB) har avgivit...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Announces That Its Subsidiary Levena and Its Partner Escugen Have Received Clearance to Begin Clinical Trials With Anti-TROP-2 Antibody Drug Conjugate For Multiple Solid Tumors
July 21, 2021 14:09 ET | Sorrento Therapeutics, Inc.
Anti-TROP-2 coupled to SN38 (a DNA polymerase inhibitor) (ESG-401) has received approval to begin clinical trials.ESG-401 addresses a highly unmet need for the treatment of multiple solid tumors,...
AMR Logo.png
Global Monoclonal Antibodies Market is Expected to Reach $390.58 Billion by 2030: Says AMR
July 20, 2021 08:34 ET | Allied Market Research
Portland, OR, July 20, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Monoclonal Antibodies Market was estimated at $146.64 billion in 2020 and is...
QMI-Logo-Long-1000px.jpg
Global Next Generation Cancer Diagnostics Market Size to Grow at a CAGR of 19.8% from 2021 to 2030
July 19, 2021 06:30 ET | Quince Market Insights
Pune, India, July 19, 2021 (GLOBE NEWSWIRE) -- The global next generation cancer diagnostics market is anticipated to reach USD 5,650.9 million in 2021 and is projected to grow at a CAGR of 19.8%...
Attachment.jpg
Mountain Valley MD Announces Appointment of Advisors, Stock Option Grant and Provides Uplisting Update
July 15, 2021 08:45 ET | Mountain Valley MD Holdings Inc.
TORONTO, July 15, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to announce the appointment of Gokul Kannan and...
Inspirata Partners with King’s Health Partners ECMC and Guy’s and St Thomas’ NHS Foundation Trust to Evaluate the Application of AI Automation in Matching Patients with Cancer to Early Phase Clinical Trials
July 13, 2021 04:00 ET | Inspirata, Inc.
London, United Kingdom, July 13, 2021 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology provider Inspirata announced today that King’s Health Partners ECMC and Guy’s and St Thomas’ NHS...
FStar.jpg
F-star Therapeutics to Present at Upcoming Investor Conferences
July 09, 2021 08:00 ET | F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., July 09, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next...